Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1. (Q43551866)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1. |
scientific article |
Statements
1 reference
Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1. (English)
1 reference
T S Weiser
1 reference
Z S Guo
1 reference
G A Ohnmacht
1 reference
M L Parkhurst
1 reference
P Tong-On
1 reference
F M Marincola
1 reference
M R Fischette
1 reference
X Yu
1 reference
G A Chen
1 reference
J A Hong
1 reference
J H Stewart
1 reference
D M Nguyen
1 reference
S A Rosenberg
1 reference
D S Schrump
1 reference
1 March 2001
1 reference
1 reference
1 reference
Identifiers
1 reference